Mind Medicine (MMED.E) tries to build a bridge between microdosing culture and science

June 3, 2020 by Joseph Mortonscience Scientists don’t have all the answers—if they did they would be out of a job—and sometimes that answer isn’t good enough. Especially for people who are suffering. They want the answer to their pain and discomfort. It’s not an unreasonable assertion. Having lived with a number of people dealing with varieties of physical and emotional […]

Mind Medicine (MMED.E) gathers people willing to try ibogaine for science

March 25, 2020 by Joseph Mortonibogaine Mind Medicine (MMED.E) started enrolling candidates for further human safety trial studies of 18-MC, the company’s orally taken ibogaine derivative for the treatment of opioid addiction. Clinical studies for ibogaine started in the early 1990’s, but closed down due to concerns that various toxins found inside weakened the heart’s ability to pump blood through the […]

Champignon Brands (SHRM.C) acquires a craft mushroom cultivator, and gives taste-tests in Toronto

March 18, 2020 by Joseph Mortoncraft mushroom Champignon Brands (SHRM.C) announced their acquisition of British Columbia-based craft mushroom cultivator and supplier Artisan Growers earlier this week. This acquisition will help SHRM expedite their push towards vertical integration through the development of their craft mushroom production, manufacturing and research capabilities. “With the acquisition of Artisan Growers, we continue to optimize our upstream, downstream […]


Nutritional High International (EAT.C) expands their psychoactive research to include peyote

June 1, 2020 by Joseph Mortonpeyote Nutritional High International (EAT.C) signed an LOI to acquire Kruzo LLC, a company involved in development and research of products surrounding the psychoactive cacti peyote, as well as other plant-based medicinal products derived from Asian herbal medicine. Mescaline is the psychoactive compound in the peyote cactus. It bears some similarities to psilocybin, but is distinctively […]

New Leaf Brands (NLB.C) subsidiary Mydecine’s new facility aims to unlock the potential in psilocybin mushrooms

May 20, 2020 by Joseph Mortonmydecine A randomized, double-blind trial from Johns Hopkins in 2016 found that a single dose of psilocybin substantially improved quality of life and decreased depression and anxiety in people with life-threatening cancer diagnoses. Based on this information there has been a movement in a number of different states to decriminalize medical psilocybin for the purpose of […]

Champignon Brands (SHRM.C) Orange County expansion digs further into California, gets into ketamine

May 13, 2020 by Joseph Mortonketamine Champignon Brands (SHRM.C) recent term sheet with California-based Wellness Clinic of Orange County not only furthers the company’s North American clinical expansion, but gives them access to an entirely new market: ketamine. The Wellness Clinic owns and operates a ketamine infusion treatment centre within the Mission Hospital’s Laguna Beach campus. The clinic offers ketamine infusion […]

Yield Growth (BOSS.C) sets up clinical trial to determine whether mushrooms are good for weight loss

May 8, 2020 by Joseph Mortonweight There’s a fair amount of excitement bubbling up over the potential for a market in psychedelics. Mostly, we’re hearing about psilocybin and psilocin, the active psychedelic components in magic mushrooms, but we’ll sometimes hear about companies doing business in some of the more exotics—like LSD, or ibogaine. But as we keep saying, it’s early yet. […]